Related Experiment Videos
Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma
Summary
A patient with phosphaturic osteomalacia experienced symptom resolution after a mesenchymal chondrosarcoma was removed. Tumor removal normalized phosphate excretion and healed osteomalacia, suggesting the tumor produced substances affecting phosphate levels.
Area of Science:
- Endocrinology
- Oncology
- Bone Metabolism
Background:
- Phosphaturic osteomalacia is a rare condition characterized by impaired bone mineralization and excessive phosphate excretion.
- This case presents a patient with phosphaturic osteomalacia lacking typical signs of hyperparathyroidism.
Observation:
- The patient showed partial improvement with vitamin D and phosphate therapy, but persistent phosphaturia.
- Surgical removal of a mesenchymal chondrosarcoma from the foot led to rapid resolution of phosphaturia and osteomalacia.
Findings:
- Preoperative and postoperative vitamin D metabolite levels did not explain the observed changes in phosphate excretion.
- Post-tumor removal, urinary cyclic adenosine monophosphate (cAMP) and bone histology normalized within a year.
Implications:
- This case suggests that certain tumors can secrete factors causing non-parathyroid mediated phosphaturia.
- The findings indicate a potential paraneoplastic syndrome involving phosphate wasting, independent of vitamin D metabolism alterations.